Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Toll-like receptors as targets in chronic liver diseases.

Mencin A, Kluwe J, Schwabe RF.

Gut. 2009 May;58(5):704-20. doi: 10.1136/gut.2008.156307.

2.

Interleukin-10: new perspectives on an old cytokine.

Mosser DM, Zhang X.

Immunol Rev. 2008 Dec;226:205-18. doi: 10.1111/j.1600-065X.2008.00706.x. Review.

3.

Bone marrow-derived immune cells mediate sensitization to liver injury in a myeloid differentiation factor 88-dependent fashion.

Hritz I, Velayudham A, Dolganiuc A, Kodys K, Mandrekar P, Kurt-Jones E, Szabo G.

Hepatology. 2008 Oct;48(4):1342-7. doi: 10.1002/hep.22557.

PMID:
18798338
4.

The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88.

Hritz I, Mandrekar P, Velayudham A, Catalano D, Dolganiuc A, Kodys K, Kurt-Jones E, Szabo G.

Hepatology. 2008 Oct;48(4):1224-31. doi: 10.1002/hep.22470.

PMID:
18792393
5.

TRIF and IRF-3 binding to the TNF promoter results in macrophage TNF dysregulation and steatosis induced by chronic ethanol.

Zhao XJ, Dong Q, Bindas J, Piganelli JD, Magill A, Reiser J, Kolls JK.

J Immunol. 2008 Sep 1;181(5):3049-56.

6.

Toll-like receptors and adaptor molecules in liver disease: update.

Seki E, Brenner DA.

Hepatology. 2008 Jul;48(1):322-35. doi: 10.1002/hep.22306. Review.

PMID:
18506843
7.

Mechanisms for the anti-inflammatory effects of adiponectin in macrophages.

Huang H, Park PH, McMullen MR, Nagy LE.

J Gastroenterol Hepatol. 2008 Mar;23 Suppl 1:S50-3. doi: 10.1111/j.1440-1746.2007.05284.x. Review.

PMID:
18336664
8.

TLR4 enhances TGF-beta signaling and hepatic fibrosis.

Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA, Schwabe RF.

Nat Med. 2007 Nov;13(11):1324-32. Epub 2007 Oct 21.

PMID:
17952090
9.

Kupffer cell heterogeneity: functional properties of bone marrow derived and sessile hepatic macrophages.

Klein I, Cornejo JC, Polakos NK, John B, Wuensch SA, Topham DJ, Pierce RH, Crispe IN.

Blood. 2007 Dec 1;110(12):4077-85. Epub 2007 Aug 9.

10.

Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis.

Rivera CA, Adegboyega P, van Rooijen N, Tagalicud A, Allman M, Wallace M.

J Hepatol. 2007 Oct;47(4):571-9. Epub 2007 Jun 8.

11.
12.

Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis.

Karrar A, Broomé U, Södergren T, Jaksch M, Bergquist A, Björnstedt M, Sumitran-Holgersson S.

Gastroenterology. 2007 Apr;132(4):1504-14. Epub 2007 Jan 25.

PMID:
17408653
13.

TLR signaling.

Kawai T, Akira S.

Semin Immunol. 2007 Feb;19(1):24-32. Epub 2007 Feb 1. Review.

PMID:
17275323
14.

Contribution of Toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria.

Elson G, Dunn-Siegrist I, Daubeuf B, Pugin J.

Blood. 2007 Feb 15;109(4):1574-83. Epub 2006 Oct 12.

15.

Pattern recognition receptors: a contemporary view on liver diseases.

Szabo G, Dolganiuc A, Mandrekar P.

Hepatology. 2006 Aug;44(2):287-98. Review.

PMID:
16871558
17.

Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells.

Tsung A, Hoffman RA, Izuishi K, Critchlow ND, Nakao A, Chan MH, Lotze MT, Geller DA, Billiar TR.

J Immunol. 2005 Dec 1;175(11):7661-8.

18.

Achieving stability of lipopolysaccharide-induced NF-kappaB activation.

Covert MW, Leung TH, Gaston JE, Baltimore D.

Science. 2005 Sep 16;309(5742):1854-7.

19.

Endotoxin and Kupffer cell activation in alcoholic liver disease.

Wheeler MD.

Alcohol Res Health. 2003;27(4):300-6. Review.

20.

Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation.

Dolganiuc A, Oak S, Kodys K, Golenbock DT, Finberg RW, Kurt-Jones E, Szabo G.

Gastroenterology. 2004 Nov;127(5):1513-24.

PMID:
15521019

Supplemental Content

Support Center